BenevolentAI
BenevolentAI is a leading, clinical-stage AI-enabled drug discovery company.
Launch date
Employees
Market cap
AUD178m
Enterprise valuation
AUD114m (Public information from Sep 2024)
Share price
€0.71 BAI.AS
Company register number 09781806
London England (HQ)
Authorizing premium user...